Zachary Bogue is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 9,378 shares of RXRX, which is worth approximately $66,583. The most recent transaction as insider was on Jul 03, 2023, when has been sold 1,440 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.38K
0% 3M change
0% 12M change
Total Value Held $66,583

Zachary Bogue Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2023
BUY
Grant, award, or other acquisition
-
1,440 Added 13.31%
9,378 Class A Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
1,542 Added 16.27%
7,938 Class A Common Stock
Jan 03 2023
BUY
Grant, award, or other acquisition
-
1,407 Added 18.03%
6,396 Class A Common Stock
Oct 03 2022
BUY
Grant, award, or other acquisition
-
977 Added 16.38%
4,989 Class A Common Stock
Jul 01 2022
BUY
Grant, award, or other acquisition
-
1,260 Added 23.9%
4,012 Class A Common Stock
Apr 01 2022
BUY
Grant, award, or other acquisition
-
1,382 Added 33.43%
2,752 Class A Common Stock
Jan 03 2022
BUY
Grant, award, or other acquisition
-
589 Added 30.07%
1,370 Class A Common Stock
Oct 01 2021
BUY
Grant, award, or other acquisition
-
295 Added 27.42%
781 Class A Common Stock
Jul 01 2021
BUY
Grant, award, or other acquisition
-
295 Added 50.0%
295 Class A Common Stock
ZB

Zachary Bogue

Director
Palo Alto, CA

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX